Back

Uncoupling of nitric oxide synthase produces a mechanistically defined murine model of heart failure with preserved ejection fraction

28 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers for HFpEF Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mrs Savi Gupta

Ottawa Hospital Research Institute, Ottawa (Canada)

5 More presentations in this session

Presentation thumbnail
Clinical implications of hyposelenium in heart failure with preserved ejection fraction
Doctor S. Watanabe (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Association between early NLPR3 changes and outcomes after heart failure hospitalization in patients with heart failure and preserved ejection fraction
Ms V. Peric (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Myocardial histopathologic phenogroups and differential prognostic implications in heart failure with preserved versus reduced ejection fraction
Doctor G. Tersalvi (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of cardiac 123I-metaiodobenzylguanidine imaging in heart failure with preserved ejection fraction
Doctor Y. Chang (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
C-type natriuretic peptide attenuates diastolic dysfunction and cardiac fibrosis in a rat model of heart failure with preserved ejection fraction
Professor T. Soeki (Tokushima, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers for HFpEF

The Event

Event poster

ESC Congress 2026

28 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
ACEI plus GLP1-RA or SGLT2i, as well as ARNI, exerted distinct protective effects against diabetic nephropathy and heart failure with preserved ejection fraction in eNOS-/- dbdb mice.
11 May 2026
thumbnail
Congress Presentation
Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction
20 May 2025
thumbnail
Congress Presentation
Combination of an oral H2S donor to dapagliflozin provides additional therapeutic benefit in a cardiorenal model of heart failure with preserved ejection fraction (HFpEF)
31 August 2025
thumbnail
Congress Presentation
Dietary nitrate enhances cardiac function in HFrEF by improving hemodynamics, ameliorating remodeling and resolving inflammation
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources